NewsGalen Robotics, Inc. Launches Bridge Funding Round Following FDA Approval

September 22, 2023by Galen Robotics0

Enhanced Funding Set to Bolster Materials Acquisitions And Manufacturing Capacity

BALTIMORE, MD – September 22, 2023 – Galen Robotics, Inc., a pioneering developer of a new breed of robotically assisted surgical systems, today announced the opening of a bridge round into its series B financing. This unique financial opportunity comes at an exciting juncture for the company immediately after its Galen ES cooperatively controlled robotic surgical assistant received a De Novo grant from the U.S. Food and Drug Administration (FDA).

As part of this bridge round, a discount on Series B pricing is being extended to qualified investors. Those interested may access additional details by directly contacting the company at

This latest round of funding is designed to substantially boost the company’s growth and advancement in the near term. The new capital will contribute significantly in securing materials for Galen Robotics and in fortifying its manufacturing capabilities, which are expanding in response to the outstanding positive market sentiment on the heels of the De Novo grant.

“This bridge round marks the advent of an exciting phase in our journey,” stated Bruce W Lichorowic, CEO, Galen Robotics. “The additional funding will play a pivotal role in boosting our operating capabilities and manufacturing domain. The impressive reception we received from our Galen ES De Dovo further bolsters our commitment to continue pushing the boundaries, leading to improved patient care and surgical outcomes.”

The strategic infusion of additional funds will contribute to our continue research and development to expand the indications for the Galen ES, underscoring Galen Robotics’ deep commitment to harnessing advanced surgical technology for improving patients’ lives.


Galen Robotics is the pioneer of Digital-Surgery-as-a-Service (DSaaS). Galen provides the world’s first cooperatively powered robotic surgical assistant platform for Ear, Nose, and Throat (ENT) surgery. Galen Robotics was founded in 2016, bringing together Silicon Valley resources and the groundbreaking work and research in surgical robotics at Johns Hopkins University. Galen Robotics is headquartered in Baltimore, Maryland.

Forward-Looking Statements Disclaimer
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These are not statements of historical facts but are forecasts, assumptions, and expectations regarding future events, and are subject to risks, uncertainties, and other factors that may cause actual results to significantly differ. Galen Robotics, Inc. undertakes no obligation to update or review any forward-looking statement.

Media Contact:
Galen Robotics, Inc.
Investor Relations

Galen Robotics Public Relations (408) 502-5960 x 717

For more information about Galen Robotics, please see 

“Galen Robotics” is a registered trademark of Galen Robotics, Inc.

“Galen ES” is a registered trademark of Galen Robotics, Inc.


Leave a Reply

Your email address will not be published. Required fields are marked *